SI1812422T1 - Polymorph form of irbesartan - Google Patents

Polymorph form of irbesartan

Info

Publication number
SI1812422T1
SI1812422T1 SI200531839T SI200531839T SI1812422T1 SI 1812422 T1 SI1812422 T1 SI 1812422T1 SI 200531839 T SI200531839 T SI 200531839T SI 200531839 T SI200531839 T SI 200531839T SI 1812422 T1 SI1812422 T1 SI 1812422T1
Authority
SI
Slovenia
Prior art keywords
irbesartan
polymorph form
polymorph
Prior art date
Application number
SI200531839T
Other languages
Slovenian (sl)
Inventor
Ljubomir Antoncic
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of SI1812422T1 publication Critical patent/SI1812422T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200531839T 2004-11-11 2005-11-09 Polymorph form of irbesartan SI1812422T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200400308 2004-11-11
EP05802257.5A EP1812422B1 (en) 2004-11-11 2005-11-09 Polymorph form of irbesartan
PCT/EP2005/011982 WO2006050923A1 (en) 2004-11-11 2005-11-09 Polymorph form of irbesartan

Publications (1)

Publication Number Publication Date
SI1812422T1 true SI1812422T1 (en) 2014-05-30

Family

ID=36121341

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531839T SI1812422T1 (en) 2004-11-11 2005-11-09 Polymorph form of irbesartan

Country Status (5)

Country Link
US (1) US20090208573A1 (en)
EP (1) EP1812422B1 (en)
ES (1) ES2454197T3 (en)
SI (1) SI1812422T1 (en)
WO (1) WO2006050923A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007099555A2 (en) * 2006-02-17 2007-09-07 Alembic Limited Pharmaceutical tablet compositions containing irbesartan
WO2008018843A1 (en) * 2006-08-08 2008-02-14 Ulkar Kimya Sanayi Ve Ticaret As Process for producing useful salts form of biphenyl-tetrazole compounds
RU2465900C2 (en) * 2007-04-17 2012-11-10 Рациофарм Гмбх Irbesartan-containing pharmaceutical compositions
CN113648281B (en) * 2021-09-24 2023-01-17 宁夏医科大学 Polymorphic irbesartan nanosuspension and preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725987B1 (en) * 1994-10-19 1997-01-10 Sanofi Sa PROCESS FOR THE PREPARATION OF A TETRAZOLE DERIVATIVE IN TWO CRYSTALLINE FORMS AND NOVEL CRYSTALLINE FORM THEREOF
FR2780403B3 (en) 1998-06-24 2000-07-21 Sanofi Sa NOVEL FORM OF IRBESARTAN, METHODS FOR OBTAINING SAID FORM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
CA2469656A1 (en) * 2001-12-10 2003-06-19 Dr. Reddy's Laboratories Limited Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one
DE10301371A1 (en) * 2003-01-16 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treatment or prophylaxis of cardiovascular, cardiopulmonary or renal diseases, e.g. hypertension combined with hyperlipidemia or atherosclerosis, using combination of telmisartan and atorvastatin
AU2003242984A1 (en) * 2003-04-07 2004-11-01 Hetero Drugs Limited A novel crystalline form of irbesartan
WO2005051943A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Processes for the preparation of highly pure irbesartan
WO2006001026A1 (en) 2004-06-23 2006-01-05 Hetero Drugs Limited Irbesartan polymorphs

Also Published As

Publication number Publication date
EP1812422B1 (en) 2013-12-25
ES2454197T3 (en) 2014-04-09
EP1812422A1 (en) 2007-08-01
US20090208573A1 (en) 2009-08-20
WO2006050923A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
PT1778618E (en) Synthesis of triethylenetetramines
PL1802579T3 (en) Derivatives of 3-arylaminopyridine
IL181587A0 (en) Production of ??-abeta
IL216401A0 (en) Sustained release of antinfectives
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
EP1756092A4 (en) Novel inhibitors of rho-kinases
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
IL187301A0 (en) Methods of synthesizing 6 - alkylaminoquinoline derivatives
IL209964A0 (en) Use of organic compounds
IL185757A0 (en) Methods of decreasing calcifcation
PL1931842T3 (en) Set of profiles
EP1711484A4 (en) Synthesis of cyanoimino-benzoimidazoles
EP1804582A4 (en) Polymorphic forms of tadalafil
IL181185A0 (en) Novel polymorphs of azabicyclohexane
GB0504314D0 (en) Novel polymorph
ZA200703495B (en) Process for the preparation of irbesartan hydrochloride
EP2057144A4 (en) Novel polymorphs of rimonabant
SI1812422T1 (en) Polymorph form of irbesartan
GB0618703D0 (en) Synthesis of leikotriene compounds
ZA200803678B (en) An improved process for preparation of Irbesartan
ZA200703630B (en) Polymorphs of sarsapogenin
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
IL186143A0 (en) Pro-drugs of n-thiazol-2yl-benzamide derivatives
AU158365S (en) Set of fins for surfcraft